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Abstract
Introduction: Mechanical ventilation (MV) with high tidal volumes may induce or aggravate lung injury in critical
ill patients. We compared the effects of a protective versus a conventional ventilatory strategy, on systemic and
lung production of tumor necrosis factor-a (TNF-a) and interleukin-8 (IL-8) in patients without lung disease.
Methods: Patients without lung disease and submitted to mechanical ventilation admitted to one trauma and one
general adult intensive care unit of two different university hospitals were enrolled in a prospective randomized-
control study. Patients were randomized to receive MV either with tidal volume (VT) of 10 to 12 ml/kg predicted
body weight (high VT group) (n = 10) or with VT of 5 to 7 ml/kg predicted body weight (low VT group) (n = 10)
with an oxygen inspiratory fraction (FIO2) enough to keep arterial oxygen saturation >90% with positive end-
expiratory pressure (PEEP) of 5 cmH2O during 12 hours after admission to the study. TNF-a and IL-8 concentrations
were measured in the serum and in the bronchoalveolar lavage fluid (BALF) at admission and after 12 hours of
study observation time.
Results: Twenty patients were enrolled and analyzed. At admission or after 12 hours there were no differences in
serum TNF-a and IL-8 between the two groups. While initial analysis did not reveal significant differences,
standardization against urea of logarithmic transformed data revealed that TNF-a and IL-8 levels in bronchoalveolar
lavage (BAL) fluid were stable in the low VT group but increased in the high VT group (P = 0.04 and P = 0.03). After
12 hours, BALF TNF-a (P = 0.03) and BALF IL-8 concentrations (P = 0.03) were higher in the high VT group than in
the low VT group.
Conclusions: The use of lower tidal volumes may limit pulmonary inflammation in mechanically ventilated patients
even without lung injury.
Trial Registration: Clinical Trial registration: NCT00935896
Introduction
Clinical studies suggest that mechanical ventilation (MV)
can modify inflammatory responses in patients with
acute lung injury. In such patients, with existing pulmon-
ary and systemic inflammation, ventilation with tidal
volumes (VT)o f1 0t o1 5m L / k gp r e d i c t e db o d yw e i g h t
and low-to-moderate levels of positive end expiratory
pressure (PEEP) was associated with increased intraalveo-
lar and systemic levels of inflammatory mediators [1]. In
contrast, mechanical ventilation with moderate-to-high
levels of PEEP and low VT of approximately 6 mL/kg pre-
dicted body weight assured adequate gas exchange,
decreased intraalveolar and systemic mediator levels, and
improved outcome [1-4]. Experimental data suggest that
mechanical ventilation with higher VT and zero end-
expiratory pressure (ZEEP) induces not only cytokine
release but also translocation of cytokines from the lungs
to the systemic circulation and even vice versa [5-7]. The
clinical repercussion of these studies is uncertain because
unphysiologically large VTs and no PEEP were generally
compared to low VT and PEEP.
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continuing systemic inflammatory reaction, it is not
clear if MV by itself can initiate lung inflammation.
Observational studies have showed that a lung inflam-
matory response could be induced after conventional
and prolonged mechanical ventilation in a mixed popu-
lation of critically ill patients [8,9]. Retrospective obser-
vations suggest that higher VTs may be deleterious after
prolonged ventilation or major surgery [9,10]. Three
randomized studies on surgical patients suggested that a
pulmonary inflammatory response could be induced by
a short-term mechanical ventilation (up to 10 hours)
even in lungs without pre-existing injury [11-13]. How-
ever, most studies used high VT and no PEEP in com-
parison to low VT and PEEP. Thus, it is not known
whether short-term mechanical ventilation with PEEP
and moderate to high VT could induce signs of pulmon-
ary or/and a systemic inflammation.
We hypothesized that lung-protective mechanical ven-
tilation with lower tidal volumes, as compared to con-
ventional mechanical ventilation induces less
inflammation in critically ill patients without evidence of
lung disease. To test this hypothesis, we measured
tumour necrosis factor-alpha and interleukin-8 in the
plasma and in the bronchoalveolar lavage (BAL) while
patients were mechanically ventilated with lung-protec-
tive or conventional strategies.
Grant CAPES-PROF, Faculdade de Medicina - Federal
University of Rio Grande do Sul.
Materials and methods
Patient selection
Twenty patients admitted to a clinical-surgical (Com-
plexo Hospitalar Santa Casa) and trauma (Hospital de
Pronto Socorro) ICU were enrolled in a randomized and
prospective study. Approval of both institutional Ethics
Committees for the study protocol was obtained and all
patients (or next of kin) gave written informed consent
before inclusion in the study.
Inclusion criteria were: 1) age ≥16 years; 2) anticipated
survival >24 hours; 3) need for mechanical ventilation for
at least 12 hours and 4) hemodynamic stability (MAP
>65 mmHg, HR <100 beats/minute, diuresis >1 ml/kg/h,
no catecholamine requirement or fluid challenge).
Exclusion criteria included thoracic surgical proce-
dures, use of immunosuppressive medication, recent
infections, previous thromboembolic disease, recent ven-
tilatory support, and participation in another clinical
trial. Absence of lung disease was defined by the follow-
ing clinical criteria: (a) no evidence of respiratory infec-
tion (white blood cell count <10 × 10
3/μl, temperature
>38°C, purulent sputum), (b) normal chest roentgen-
ogram, (c) ratio between arterial oxygen tension and
inpired oxygen tension (PaO2/FIO2) >300, (d) and a nor-
mal clinical respiratory history.
Patients were on mechanical ventilation for a maxi-
m u mo f1 2h o u r sa tt h et i m eo fi n i t i a t i n go n eo ft h e
two randomized MV strategies, including the surgical
period. On ICU admission, the following standard venti-
lation protocol was applied: patients were continuously
sedated (benzodiazepines and/or opioids), remained
supine and were ventilated with intermittent positive
pressure ventilation, assist/control mode on a Siemens
Elema 900C Servo ventilator (Solna, Sweden). VT,
respiratory rate, and fraction of inspired oxygen (FIO2)
were adjusted to maintain arterial oxygen saturation >
90%, PaCO2 of 35 to 45 mmHg and pH > 7.25. PEEP
w a sk e p ta t5c m H 2O. The inspiratory:expiratory (I:E)
ratio was 1:2. All ventilator circuits were equipped with
a heat-moisture exchanger.
Disease severity was scored with the Acute Physiology
and Chronic Health Evaluation (APACHE) II scoring
system [14].
Measurements and study protocol
Immediately after ICU admission, once all inclusion and
exclusion criteria were met and consent obtained, 20
patients were randomly (opaque sealed envelopes)
assigned to receive mechanical ventilation in volume-
controlled mode either with VT of 10 to 12 ml/kg pre-
dicted body weight (high VT group, n = 10) or with VT
of 5 to 7 ml/kg predicted body weight (low VT group,
n = 10) with an inspiratory fraction of oxygen (FIO2) set
at the minimal level at which an arterial oxygen satura-
tion of >90% and minimal PEEP (4 to 5 cmH2O). I:E
ratio was 1:2. The predicted body weight of male
patients was calculated as equal to 50 + 0.91(centimeters
of height-152.4); that of female patients was calculated
as equal to 45.5 + 0.91(centimeters of height-152.4) [4].
Baseline serum and BAL samples for tumor necrosis
factor-alpha (TNF-a) and interleukin-8 (IL-8) measure-
ments were taken. Additional serum and BAL samples
were obtained 12 h after randomization for comparison.
All blood and BAL samples were collected and handled
by the same investigator. All patients remained supine
throughout the study period. The following ventilatory
variables were measured at baseline and 12 hours: tidal
volume (VT), minute ventilation (VE), inspiratory time
(TI), expiratory time (TE), positive end-expiratory pres-
sure (PEEP), peak inspiratory pressure (Ppeak), and pla-
teau pressure after end-inspiratory pause (Pplateau) [3].
All patients received sedation and analgesia to keep
them comfortable while on mechanical ventilation.
Patients were not left on ventilation for the study and
one patient was extubated and excluded from the analy-
sis before protocol initiation.
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BAL was performed by instillating 100 ml sterile iso-
tonic saline (five aliquots of 20 ml) in segments of the
right lower lobe and sequentially suctioned; 30% to 50%
of this aliquot was recovered. The first aliquot was dis-
charged. During bronchoscopy FIO2 was kept at 100%.
Lavage fluids were filtered through sterile gauze filters,
collected on ice, and immediately centrifuged at 1,500 g
for 10 minutes. Supernatant aliquots were kept frozen at
-40°C for subsequent analysis.
Blood measurements
Venous ethylenediaminetetraacetic acid (EDTA) blood
samples from fresh puncture sites of 10 ml were
obtained and immediately centrifuged at 1,500 g for 10
minutes; the plasma was aspirated and stored at -40°C.
Cytokines measurements
Commercially available ELISA assays were used to mea-
sure BAL and plasma levels of human interleukin 8 (IL-
8), tumor necrosis factor alpha (TNF-a) (R&D Systems,
Minneapolis, MN, USA). All enzyme-linked immunosor-
bent assays were performed according to the manufac-
turers’ guidelines. All samples from one patient were
analyzed in the same assay run. The samples were mea-
sured in duplicates by the same technician who was
blinded to ventilation strategy. Samples were assayed for
each 10 patients and a randomization code broken. The
sensitivities of the test kits were as follows: IL-8: 1.5 pg/
mL and TNF-a: 0.5 pg/mL.
Standardization of cytokine concentrations in BAL with
urea
The technique of BAL is based on the concept that ali-
quots of sterile normal saline solution infused through
the bronchoscope mix with epithelial lining fluid (ELF).
The use of urea to quantify the amount of ELF recov-
ered by BAL is based on the knowledge that urea is
freely diffusible through most body compartments,
including the lungs. Urea concentration was measured
in BAL fluid and blood and ELF volume calculated
according to the formula described below [15]. In this
context, if the concentration of urea in plasma is known
and the quantity of urea in a lavage sample is measured,
the volume of recovery ELF can be calculated as:
Volume of ELF (mL) = total amount urea in BALF
(mg)/concentration of urea in plasma (mg/mL) (I)
The cytokine concentrations in the ELF were then cal-
culated as:
Cytokine of ELF (pg/mL) = total amount of cytokine
in BALF (pg/mL)/volume of ELF (II)
Statistical analysis
The required sample size was calculated from previous
studies on ventilatory strategies in patients during major
surgeries [11,16] and after the first 10 patients’ analyses.
To detect differences in the time course of plasma TNF-
a between the ventilatory settings with respect to the
two groups with the given two-tailed parallel design at a
significance level of 5% (a = 0.05) with a probability of
80% (b = 0.20) based on an estimated difference of 0.76
of the parameter’s mean standard deviation, the number
of patients to be studied in each group was 10. Data
were tested for normal distribution with the Kolmo-
gorov-Smirnov test. Differences within groups were ana-
lyzed with a t-test or Wilcoxon signed-rank test for
paired samples. Student t-test or Mann-Whitney U test
were used to compare the changes over time between
the two randomization groups as appropriate. Logarith-
mic transformation of BAL urea cytokines values was
also used to stabilize the variance and to permit the
application of a parametric test. Differences were con-
sidered to be statistically significant at the level of P <
0.05. Results are expressed as mean ± standard deviation
or median (25
th to 75
th percentiles).
Results
The two groups of patients did not differ significantly in
demographic or clinical data (Table 1). For the nine sur-
gical patients, the median surgery duration was 470
Table 1 Demographic and clinical data
High VT (n =
10)
Low VT (n =
10)
P
value
Age (years) 52 ± 18 46 ± 18 0.43
Gender: M/F 7/3 9/1 0.58
APACHE II 16.0 ± 8.6 13.2 ± 6.5 0.42
Scheduled surgery
￿ Gastrointestinal 3 4
￿ Vascular 1
￿ Other 1
Clinical diagnosis
￿ Head trauma 2 4
￿ Stroke 2 2
￿ Other 1
Lenght of ICU stay
(days)
6.6 ± 5.0 7.7 ± 7.6 0.71
Duration of MV (days) 3 [1 to 5] 7 [1 to 9] 0.65
28
th Mortality rate (%) 40 30 1.00
VT, tidal volume; APACHE, Acute Physiology and Chronic Health Evaluation;
MV, mechanical ventilation.
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each group received up to two packed red blood cells
during surgery. Blood transfusions or surgical interven-
tions were not required during the 12 hours study
period.
Ventilatory and blood gases parameters are shown in
Table 2. As expected, VT, plateau pressure and peak
pressure became higher in the high VT group through-
out the 12 h observation time. Although not signifi-
cantly, PaCO2 and HCO3 values were lower in the high
VT group enough to keep pH values stable after 12 h.
Plasma cytokine levels were similar between the two
ventilatory strategies at admission and after 12 h of
observation time (Figure 1). Plasma levels of TNF-a
remained below the detection limit (0.5 pg/ml) in three
patients of the low VT group and in two patients of the
high VT group both at baseline and after 12 h of
mechanical ventilation.
At baseline, BAL cytokines concentrations were similar.
BAL IL-8 levels in the low VT group remained stable (96
(49 to 553) pg/ml vs. 82 (32 to 500) pg/ml, P =0 . 8 4 )b u t
increased in the high VT group (41(10 to 210) pg/ml vs.
328 (50 to 1,000) pg/ml, P =0 . 0 1 )w i t h o u td i f f e r e n c e s
between groups after 12 hours (P =0 . 2 7 ) .A f t e ru r e a
standardization, BALF IL-8 values tended to increase in
the high VT (450 (130 to 20,678) pg/ml vs. 5,000 (2,096
to 14,437) pg/ml, P = 0.19) and tended to decrease in the
low VT (1,809 (735 to 953) pg/ml vs. 1,243 (242 to 2,746)
pg/ml, P = 0.20) with significant differences 12 hours
later (P =0 . 0 4 2 ) .B A LT N F - a decreased in the low VT
group (12.3 (11.0 to 12.4) pg/ml vs. 6.6 (5.8 to 7.4) pg/ml,
P = 0.23) but increased in the high VT group (1.7 (1.62 to
1.8) pg/ml vs. 22.0 (10.5 to 22.1) pg/ml, P =0 . 0 6 )w i t h
significant differences between groups 12 hours later
(P = 0.04). Similarly, after urea standardization, BALF
TNF-a values tended to decreased in the low VT group
(177 (90 to 329) pg/ml vs. 87 (34 to 106) pg/ml, P = 0.09)
b u tt e n d e dt oi n c r e a s ei nt h eh i g hV T group (49 (21 to
276) vs. 262 (100 to 714), P = 0.09) with significant differ-
ences between groups 12 hours later (P = 0.034).
After logarithmic transformation, BAL-urea IL-8
values were stable in the low VT group (P =0 . 2 0 )b u t
increased in the high VT group (P = 0.03) with signifi-
cant differences after 12 hours (P = 0.03). BAL-urea
TNF-a values were stable in the low VT group
(P = 0.53) but increased in the high VT group (P = 0.04)
with significant differences after 12 hours (P =0 . 0 3 )
Figure 2.
Due to technical problems, standardization with urea
was not possible for one patient in each group.
There was no difference between the two groups with
regard to days on mechanical ventilation, intensive care
duration of stay, or 28
th day mortality rate (Table 1).
Discussion
The present study has shown that use of lower VT and
PEEP might attenuate the pulmonary inflammatory
response in near normal lungs. The major finding of the
study is that both TNF-a and IL-8 concentrations were
increased with high VT but stable with low VT in the
BAL fluid in patients ventilated without lung disease
after admission to an ICU.
Mechanical ventilation in patients without lung dis-
ease is commonly provided by using a VT around
10 ml/Kg predicted body weight and a low PEEP [16].
Few studies addressed the effects of mechanical ventila-
tion using a high VT strategy on pulmonary inflamma-
tory response in patients without lung disease, mostly
during major surgery [11,12,16-18]. In addition, data in
non acute lung injury/acute respiratory distress
Table 2 Ventilatory parameters and arterial blood gases
High VT Group Low VT Group
Time Zero 12 h Zero 12 h
VT (PBW) (ml) 11.3 ± 0.8** 11.9 ± 0.9* 6.2 ± 0.6 6.2 ± 0.7
Peak Pressure (cmH2O) 29.80 ± 8.74** 29.6 ± 7.39** 17.90 ± 2.80 17.60 ± 3.34
Plateau Pressure (cmH2O) 28.90 ± 8.71** 28.60 ± 7.32** 17.10 ± 3.03 16.70 ± 3.26
PEEP (cmH2O) 4.30 ± 0.48 4.30 ± 0.48 4.50 ± 0.52 4.50 ± 0.52
Ventilatory rate (bpm) 18.6 ± 1.4 * 18.7 ± 1.4* 20.7 ± 2.5 21.3 ± 2.2
FIO2 (%) 52.50 ± 25.41 48.50 ± 19.58 41.00 ± 2.10 41.00 ± 2.10
pH 7.38 ± 0.04 7.41 ± 0.06 7.39 ± 0.05 7.40 ± 0.04
PaO2 (mmHg) 143.60 ± 30.52 133.70 ± 32.92 146.00 ± 81.83 119.80 ± 28.76
PaCO2 (mmHg) 34.40 ± 7.32 26.60 ± 5.60 30.29 ± 8.28 31.45 ± 7.18
HCO3 (mmol/L) 20.80 ± 6.01 17.89 ± 5.56 19.71 ± 4.58 21.42 ± 5.56
SaO2 (%) 98.00 ± 2.58 98.30 ± 2.16 97.60 ± 2.27 97.90 ± 2.18
PaO2/FIO2 307 ± 101 298 ± 105 358 ± 207 293 ± 74
FIO2, inspiratory fraction of oxygen; HCO3, bicarbonate; PaCO2, partial pressure of carbon dioxide; PaO2, arterial oxygen tension; PBW, predicted body weight;
PEEP, positive end expiratory pressure; SaO2, arterial oxygen saturation; VT, tidal volume; *P < 0.01, **P < 0.001 vs. Low VT group
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spective analysis [9,19]. Our study distinguishes our
study from others as we have shown that protective ven-
tilation in near normal lung patients in an ICU scenario
is also beneficial by preventing additional injury.
We observed higher levels of IL-8 and higher TNF-a
levels in the BAL fluid of patients ventilated with high
VT without significant release of lung cytokines into the
circulation. Different clinical studies using short periods
of mechanical ventilation in patients with normal lungs
does not consistently alter plasma levels of inflammatory
mediators [11,16,20]. Recently, Wolthuis et al. have
shown in patients scheduled to undergo an elective sur-
gical procedure (lasting >5 h) that MV with VT of
12 ml/kg and no PEEP increased myeloperoxidase and
elastase in the BALF when compared to a VT of 6 ml/kg
and PEEP but not in plasma inflammatory mediators
[13]. In contrast, Michelet et al have shown that protec-
tive ventilation reduced thes y s t e m i cp r o i n f l a m m a t o r y
response after esophagectomy [12]. Their results
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Figure 1 Time course of plasma TNF-a (top) and IL-8 (bottom) levels in high tidal volume (High VT) and low tidal volume (Low VT)
groups.
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ventilation is more aggressive to the lungs and can pro-
mote a more intense ventilation-induced injury even
after a short time.
Our study differs from most previous studies. We
used high VT but with PEEP. Therefore, tidal airway clo-
sure may be attenuated and gross lung alterations in a
short time MV were avoided. The lack of significant sys-
temic or even less intense additional lung inflammation
in our study seem to be in accordance to previous
research demonstrating initiation of inflammatory
responses to injurious ventilatory strategies using high
VT and ZEEP or low PEEP [1,21-23]. It is known from
experimental research that cyclic opening and closing
from high VT and ZEEP can cause mechanical altera-
tions and histologic damage to peripheral airways and
inflammation in lungs [24-27]. Manzano et al. have
shown that application of prophylactic PEEP reduces the
number of hypoxemia episodes and the incidence of
ventilator-associated pneumonia in nonhypoxemic venti-
lated patients [28].
Although we tried to select patients without acute
lung-injury lungs, some degree of inflammation was
already present probably due to surgery, trauma, anaes-
thesia and injurious MV. For instance, we can’te x c l u d e
that the trans-hiatal manipulation on two patients after
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Figure 2 Time course of logarithmic standardized-urea bronchoalveolar lavage (Log BAL-urea) TNF-a (top) and IL-8 (bottom) levels.
There were no differences between groups at baseline.
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Our results could be explained by a multiple-hit model.
Pulmonary inflammation must already be present (first
hit) for injurious mechanical ventilation (second hit) to
aggravate the inflammatory response. Indeed, both
groups had elevated but similar lung cytokine levels at
admission with a high tidal volume strategy causing
additional increase in most patients, excluding two of
them. This hypothesis is supported by experimental stu-
dies showing increased inflammatory responses to high
VT mechanical ventilation after an inflammatory first hit
[21,9-31]. There is indeed clinical evidence supporting
this multiple-hit hypothesis. High VT ventilation was
independently associated with development of ARDS in
patients who did not have ARDS at the onset of MV in
the intensive care unit [9,19]. Furthermore, in patients
with acute lung injury or acute respiratory distress syn-
drome, a protective mechanical ventilation with low VT
ventilation with PEEP was associated with lower pul-
monary and/or systemic inflammatory mediator concen-
trations, decreased mortality when compared to
mechanical ventilation with high VT[1,2,4].
Our study did not determine the respective influence
of a reduced VT or lower plateau pressure as both are
independently associated with a decrease in ventilator-
induced lung injury [32]. Our study design did not pro-
duce similar peak and plateau pressures between groups
and in the high VT group the mean plateau pressure
was close to 30 cmH2O. Recent data suggest that there
is no safe limit for plateau pressure and also for tidal
volume [32-34]. Thus, our results can be explained by
both low VT and plateau pressures.
In our study, the higher ventilatory rate in the low VT
g r o u pn a r r o w e dd i f f e r e n c e si nP a C O 2 between groups
and pH was kept absolutely equal. Thus, hypercapnia
seems not to explain differences between groups. Hyper-
capnia may have beneficial physiological and anti-
inflammatory effects [35]. However, its role in protective
lung ventilation per se, apart from the reduced lung
stretch, remains unclear because of lack of clinical data
comparing the efficacy of protective lung ventilator stra-
tegies in the presence and absence of hypercapnia.
The statistical difference was caused by a majority of
patients in the high VT group showing increase in BAL
cytokines. The non-uniform distribution of these data
suggests individual differences in the inflammatory
responses. In addition, saline solution instilled and sub-
sequently withdrawn can lead to a variable extent of
dilution. The use of urea as a marker of dilution, is
based on the knowledge that urea diffuses freely through
the alveolar wall. Still after correcting for dilution, cyto-
kines levels showed a non-significant increase in lung
cytokines for the high VT due to the wide variance that
became clearer after logarithmic transformation.
The study was underpowered to correlate outcome
variables and release of lung cytokines. The question on
the biological role of these mediators in terms of overall
inflammatory status or lung injury per se is not easy.
There are studies in healthy animals showing that venti-
lation-induced lung injury might be not caused directly
by the mechanical forces, but by the mediators pro-
duced in response to these forces [36,37]. Therefore, the
interaction between increased cytokines levels caused by
injurious ventilation (second hit) and others inflamma-
tory stimuli (first hit) is often difficult to define in a
clinical setting.
Additional limitations include the small number of
mixed critically ill patients and lack of true blinding.
Also, to select near normal lung patients, we planned to
include patients without independent predictors for
development of acute respiratory distress syndrome
such as shock and multiple transfusions [38] or sur-
geries involving the lungs. Although no patient devel-
oped ALI/ARDS during the clinical course, BAL
cytokines were elevated and four patients of each group
had PaO2/FIO2 <300 already at baseline. Finally, we did
not control ventilation management in the emergency
or surgical theatre, but patients met criteria for lungs
without acute injury immediately after admission to ICU
with study protocol initiation soon after.
Conclusions
In conclusion, mechanical ventilation with lower VT in
patients without lung disease resulted in attenuation of
pulmonary production of inflammatory mediators. The
finding that patients with elevated BAL cytokines levels,
immediately before initiation of the protocol, showed
higher IL-8 and TNF-a levels during higher VT ventila-
tion provides further support to the potential for injur-
ious mechanical ventilation even in patients with
previous near normal lungs. Based on our study, we
recommend using a protective ventilatory strategy.
Key messages
￿ Mechanical ventilation with lower VT in patients
without lung disease resulted in attenuation of pul-
monary production of inflammatory mediators.
￿ The use of lower tidal volumes may limit pulmonary
inflammation in mechanically ventilated patients
even without lung injury.
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